{"id":1019148,"date":"2026-11-09T18:31:08","date_gmt":"2026-11-09T23:31:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/"},"modified":"2026-11-09T18:31:08","modified_gmt":"2026-11-09T23:31:08","slug":"cellectis-to-report-third-quarter-financial-results-on-november-12-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/","title":{"rendered":"Cellectis to Report Third Quarter Financial Results on November 12, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Nov.  09, 2026  (GLOBE NEWSWIRE) &#8212; Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS- NASDAQ: CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment, will report financial results for the third quarter 2026 ending September 30, 2026 on Thursday, November 12, 2026 after the close of the U.S. market.<\/p>\n<p align=\"justify\">The publication will be followed by an investor conference call and webcast on Friday, November 13, 2026, at 8:00 a.m. ET \/ 2:00 p.m. CET. The call will include the Company\u2019s third quarter 2026 results and an update on business activities. Details for the call are as follows:<\/p>\n<p>\n        <strong>Dial in information:<\/strong><br \/>\n        <br \/>Toll Free US &amp; Canada: +1-833-354-6854<br \/>US\/International Toll: +1-785-838-9343<br \/>Conference ID: CLLSQ3<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2PthkiblYoHJtxVFouBVKAB-xTLNpmBo3T8SYYCbGaScrHYnTHqEOOaGEjcKuueldiGPxNfIzf5l0XgkS_T0xiz78LTIeZ4SaEPF_UVpAIgkEzeUx7qlC_UR53h_Cy7WffSan7cLCAthQVrlukaJiUqeDdrfZwA79tw_gFH_ccdJStiW39rkd-yDhoGbPu8-bmB_0kF0rHej7erDvfXsALBMA08m9lY9UV96keWZWTYPNWudR3HJSwmsEXEgrYQep1QxSjI_xOLgvYkH9x_RDoeHD0lnmqWN0Bf76d6HMzBY_4CqZ0dufIr2EKJ4A0VHke_azsWdVNZCWGV5Sw_Y2l2skHojf60vBhdLI8Qt6jWxrgJP8UBCCdLl5x8lND8Gthd4Wh8c8clUgYokCIJzzEJVsYcuSny5Fouc55fOt-ndhJfYJPUg237zAVhnZqtBr9N29JlCRAWXA66-bfFQ0FNM8u0xOhO5PRuDi0IEeAMIFm9aXhWS6FYjxpaHB2RDlBPTlvZtBThWdx5kTiUf3muFM6rCkyGtuktXvYBHRzBr-BA6pcHxUHqJ_89XwFkUS-5tMah-cLyfoSF5w3Bz-U8L3g-O3bMbKNQuCOBiL5mqgImdqwzmE7yJquiBKsF3YdJbmtVgMq0gBzUwYCPx5CCVHIs2ODOGd12785EmaOIJUpgbBtU1w7xVguzcxOBFHQ_Tz2hqXP9LA8Ojiikk3lqBDJs_cTxKUkh1BN11L6t1SfgrGkJYcK84gzw1wUKZjKFTHthLxX2ksPXiDfwihg==\" rel=\"nofollow\" target=\"_blank\">https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1780016&amp;tp_key=925efa50d7<\/a><\/p>\n<p align=\"justify\">\n        <strong>About\u202fCellectis<\/strong>\n      <\/p>\n<p align=\"justify\">Cellectis is a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment. Leveraging decades of expertise in programmable DNA-binding proteins, the Company has built a differentiated genome engineering platform spanning gene editing, base editing, epigenetic editing and transcriptional regulation. By delivering the genomic intervention each disease requires, Cellectis is advancing a new generation of genetic medicines designed to move beyond disease management and toward lasting therapeutic impact.<\/p>\n<p align=\"justify\">Cellectis\u2019 headquarters are in Paris, France, with locations in New York and Raleigh, NC.\u202fCellectis\u202fis listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more, visit \u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z8hxnnP2fqOsIa8w0l8zMsmMJoULaEC_BVcj9qdqHIfUPgn2Tj_yLxJ-ZlSRpDVfbuZpc1ZuAcvxtMQ9bI_hPq0Swrf8hfsFEE2QCrwdoD4=\" rel=\"nofollow\" target=\"_blank\">www.cellectis.com<\/a> \u202fand follow\u202fCellectis\u202fon \u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dhh34P60c_VixYOXl2D0f2FHT1uT--dgw8VEO8ZD9tZ5uXuajrZfV_fcvEp2YcpmvXpxNtp8U8_YFNN29jT4zfJhRgu6lXWpjkox50J4g9Qef7DNMUWtazqfRIVAIpZy\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u202f and\u202f <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qddbOekaGPrqKEFb0AnCZuZghTmOrgYK40k-P_N3caykwmZ-g3ZgCF4E56UO5eDwnQLxqvEY6zeK9BHU1sdl8A==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.\u202f\u202f<\/p>\n<p align=\"justify\">\n        <strong>For further information on\u202fCellectis, please contact:<\/strong>\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f<br \/>\u202f\u202f\u202f\u202f\u202f<br \/><strong>Media contacts:<\/strong>\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f<br \/>Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EmhPCJ00uXZvUNPzVklwBZAVMlt9eOxfB7cWZ259l2fNLjh3D1AE2nS8a3E04PBLnX672RGsp4wTqBDx8v3ZEUo0cLcPeOV_hUypGfZR-BU=\" rel=\"nofollow\" target=\"_blank\">media@cellectis.com<\/a> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Patricia Sosa Navarro, Chief of Staff to the CEO,\u202f+33 (0)7 76 77 46 93\u202f\u202f\u202f\u202f\u202f\u202f<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations contact:<\/strong>\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f\u202f<br \/>Arthur Stril, Chief Financial Officer &amp; Chief Business Officer,\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qEWZQj7YM_qshqJANW0dK08fBB3J6Mr8U1G8Y0k84L0m9xWmEJbmPxari7PNQ_SehEQZTyUq_P47-Vw55JM8WkeINAnUnxp4OSMZbwtIBDo=\" rel=\"nofollow\" target=\"_blank\">investors@cellectis.com<\/a><\/p>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a href=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/0b14096f-beec-4196-95d8-43124085acf4\" rel=\"nofollow\" target=\"_blank\">Q3 2026 announcement PR_ENGLISH.pdf<\/a>\n        <\/li>\n<\/ul>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmRmYTgyNzQtYTU5MC00ZTBhLTkxZTktNjYwMTFiOGFmMDg3LTEwNjE0NDgtMjAyNi0xMS0wOS1lbg==\/tiny\/Cellectis-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS- NASDAQ: CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment, will report financial results for the third quarter 2026 ending September 30, 2026 on Thursday, November 12, 2026 after the close of the U.S. market. The publication will be followed by an investor conference call and webcast on Friday, November 13, 2026, at 8:00 a.m. ET \/ 2:00 p.m. CET. The call will include the Company\u2019s third quarter 2026 results and an update on business activities. Details for the call are as follows: Dial in information: Toll Free US &amp; Canada: +1-833-354-6854US\/International Toll: +1-785-838-9343Conference ID: CLLSQ3Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1780016&amp;tp_key=925efa50d7 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cellectis to Report Third Quarter Financial Results on November 12, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1019148","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cellectis to Report Third Quarter Financial Results on November 12, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cellectis to Report Third Quarter Financial Results on November 12, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS- NASDAQ: CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment, will report financial results for the third quarter 2026 ending September 30, 2026 on Thursday, November 12, 2026 after the close of the U.S. market. The publication will be followed by an investor conference call and webcast on Friday, November 13, 2026, at 8:00 a.m. ET \/ 2:00 p.m. CET. The call will include the Company\u2019s third quarter 2026 results and an update on business activities. Details for the call are as follows: Dial in information: Toll Free US &amp; Canada: +1-833-354-6854US\/International Toll: +1-785-838-9343Conference ID: CLLSQ3Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1780016&amp;tp_key=925efa50d7 &hellip; Continue reading &quot;Cellectis to Report Third Quarter Financial Results on November 12, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T23:31:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cellectis to Report Third Quarter Financial Results on November 12, 2026\",\"datePublished\":\"2026-11-09T23:31:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/\"},\"wordCount\":305,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/\",\"name\":\"Cellectis to Report Third Quarter Financial Results on November 12, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=\",\"datePublished\":\"2026-11-09T23:31:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cellectis to Report Third Quarter Financial Results on November 12, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cellectis to Report Third Quarter Financial Results on November 12, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/","og_locale":"en_US","og_type":"article","og_title":"Cellectis to Report Third Quarter Financial Results on November 12, 2026 - Market Newsdesk","og_description":"NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; Cellectis (the \u201cCompany\u201d) (Euronext Growth: ALCLS- NASDAQ: CLLS), a genome engineering company developing genetic medicines for diseases that today demand a lifetime of treatment, will report financial results for the third quarter 2026 ending September 30, 2026 on Thursday, November 12, 2026 after the close of the U.S. market. The publication will be followed by an investor conference call and webcast on Friday, November 13, 2026, at 8:00 a.m. ET \/ 2:00 p.m. CET. The call will include the Company\u2019s third quarter 2026 results and an update on business activities. Details for the call are as follows: Dial in information: Toll Free US &amp; Canada: +1-833-354-6854US\/International Toll: +1-785-838-9343Conference ID: CLLSQ3Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1780016&amp;tp_key=925efa50d7 &hellip; Continue reading \"Cellectis to Report Third Quarter Financial Results on November 12, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-09T23:31:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cellectis to Report Third Quarter Financial Results on November 12, 2026","datePublished":"2026-11-09T23:31:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/"},"wordCount":305,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/","name":"Cellectis to Report Third Quarter Financial Results on November 12, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=","datePublished":"2026-11-09T23:31:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzE2NSM3OTQ4ODc1IzIwNDk4Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cellectis-to-report-third-quarter-financial-results-on-november-12-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cellectis to Report Third Quarter Financial Results on November 12, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1019148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1019148"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1019148\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1019148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1019148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1019148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}